Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013036 |
---|---|
Receipt number | R000015216 |
Scientific Title | A Randomized, Multicenter, Phase III Study to Compare 6 Months of either 5-Fluorouracil / l-leucovorin plus Oxaliplatin (mFOLFOX6) or Capecitabine plus Oxaliplatin (XELOX) with 3 Months of either mFOLFOX6 or XELOX as Adjuvant Chemotherapy in Patients with Completely Resected high-risk Stage II Colon Cancer |
Date of disclosure of the study information | 2014/01/31 |
Last modified on | 2018/02/23 14:32:01 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/01/31 18:17:15 | ||
2 | Update | 2014/02/12 08:40:02 | Recruitment status |
|
3 | Update | 2016/02/01 08:39:56 | Last follow-up date |
|
4 | Update | 2017/02/24 17:09:30 | Recruitment status |
|
5 | Update | 2018/02/23 14:25:48 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Address Address Name of primary person or sponsor Organization |
|
6 | Update | 2018/02/23 14:32:01 | Organization Organization TEL |